Company news

QuidelOrtho Corporation news in 2020

QuidelOrtho Corporation's news releases, calls and decks from 2020, newest first.

View company

Quidel Receives Emergency Use Authorization for Moderately Complex Solana® SARS Molecular Test for COVID-19 Diagnosis

December 22, 2020

Quidel Receives Emergency Use Authorization for QuickVue® SARS Rapid Antigen Test for COVID-19 Diagnosis

December 20, 2020

Quidel Corporation CEO Douglas Bryant Named Executive of the Year in MedTech Dive Awards For 2020

December 9, 2020

Quidel Corporation Hosts Upcoming Webinar to Help Health Professionals Distinguish Lyme Disease, Flu and COVID-19 During Frightening Respiratory Season

November 18, 2020

Quidel Corporation Triple Winner in International MarCom Awards Competition

November 9, 2020

Quidel to Host Virtual Investor Day on November 12, 2020

November 2, 2020

Quidel Reports Third Quarter 2020 Financial Results

October 28, 2020

Quidel Corporation Joins Global Lyme Alliance as Sponsor for the GLA ‘Fight Lyme With Avril Lavigne and Friends’ Virtual Concert Oct. 24

October 21, 2020

Quidel to Hold Third Fiscal Quarter 2020 Financial Results Conference Call on October 29th, 2020

October 18, 2020

Quidel Receives Emergency Authorization for First Rapid Antigen “ABC Test”: A Combination Diagnostic Assay for Influenza A+B and COVID-19

October 1, 2020

Quidel Announces Preliminary Revenue for Third Quarter 2020

September 30, 2020

Quidel Corporation Statement on President Trump’s Announcement of Coronavirus Testing Strategy

September 27, 2020

Quidel to Present Today at 13th Annual Piper Sandler Med-Tech and Diagnostics California Bus Tour

August 26, 2020

Quidel Provides Business Update at 13th Annual Piper Sandler Med-Tech and Diagnostic California Bus Tour; Another SARS Antigen Entrant Does Not Change Quidel’s Strategy

August 26, 2020

Webinar Discussing How Lyme Disease Affects Children to Be Held Aug. 27 and Hosted by Quidel Corporation

August 24, 2020

Quidel Concludes Sofia® SARS Antigen Investigation From Vermont

August 19, 2020

Quidel to Update Packaging of Point-of-Care Sofia® SARS Antigen Test for COVID-19 to Include Either Nasal or Nasopharyngeal Swabs

August 18, 2020

Quidel’s Lyra® Direct SARS-CoV-2 Assay Receives Health Canada Authorization

August 11, 2020

State of Maryland Allows Point-of-Care Testing for COVID-19; Quidel Expands Training Program

August 9, 2020

Quidel Receives Preliminary Contract Leading to Definitive Agreement for $71 Million Under NIH’s RADx-ATP Program to Accelerate the Expansion of Its Manufacturing Capacity for Sofia® SARS-CoV-2 Antigen Detection Test for Rapid Diagnosis of COVID-19

July 30, 2020

Quidel Reports Second Quarter 2020 Financial Results

July 29, 2020

CORRECTING and REPLACING Quidel to Present Virtually at the Canaccord Genuity 40th Annual Growth Conference

July 28, 2020

Published National Findings in Lyme Disease Testing to Be Discussed on July 30 Webinar Hosted by Quidel Corporation

July 21, 2020

Quidel’s Sofia® SARS Antigen FIA Updates EUA Performance Data to 96.7% PPA Versus PCR; Product Supports U.S. Initiatives to Expand Access to COVID-19 Testing in Nursing Homes; Receives CE Mark for Use With Sofia® and Sofia® 2 Instruments

July 16, 2020

Quidel to Hold Second Fiscal Quarter 2020 Financial Results Conference Call on July 30th, 2020

July 12, 2020

Quidel Announces Preliminary Revenue for Second Quarter 2020

July 5, 2020

Quidel Announces Jack Schuler Will Retire From Quidel’s Board of Directors

June 10, 2020

Quidel Receives Amended Emergency Authorization for Rapid Antigen COVID-19 Diagnostic Assay Using Sofia 1 Instrument

June 8, 2020

Quidel’s Lyra® Direct SARS-CoV-2 Assay Receives Emergency Use Authorization and CE Mark for Molecular Detection of COVID-19, Without Extraction Step

May 17, 2020

Quidel Receives Emergency Authorization for Rapid Antigen COVID-19 Diagnostic Assay

May 7, 2020

Quidel Reports First Quarter 2020 Financial Results

May 5, 2020

Quidel’s Lyra® Direct SARS-CoV-2 Assay Submitted for Emergency Use Authorization for Molecular Detection of COVID-19, Without Extraction Step

April 21, 2020

Quidel’s Lyra® SARS-CoV-2 Assay Receives Authorization for Expanded Use for Molecular Detection of COVID-19; Also Receives CE Mark, Health Canada Authorization

March 24, 2020

Quidel Receives Emergency Use Authorization for Molecular COVID-19 Diagnostic Assay

March 16, 2020

Quidel Reports Fourth Quarter and Full Year 2019 Financial Results

February 11, 2020

Quidel to Hold Fourth Quarter and Full Year 2019 Financial Results Conference Call on February 12th, 2020

January 27, 2020

Quidel Announces Preliminary Revenue for Fourth Quarter 2019

January 8, 2020

Calls in 2020

Decks in 2020